Parzych, Elizabeth M.
Du, Jianqiu
Ali, Ali R.
Schultheis, Katherine
Frase, Drew
Smith, Trevor R. F. http://orcid.org/0000-0002-0671-2565
Cui, Jiayan
Chokkalingam, Neethu
Tursi, Nicholas J. http://orcid.org/0000-0001-6752-3402
Andrade, Viviane M.
Warner, Bryce M.
Gary, Ebony N. http://orcid.org/0000-0002-2928-1120
Li, Yue
Choi, Jihae
Eisenhauer, Jillian
Maricic, Igor
Kulkarni, Abhijeet
Chu, Jacqueline D.
Villafana, Gabrielle
Rosenthal, Kim
Ren, Kuishu
Francica, Joseph R.
Wootton, Sarah K. http://orcid.org/0000-0002-5985-2406
Tebas, Pablo
Kobasa, Darwyn
Broderick, Kate E.
Boyer, Jean D.
Esser, Mark T. http://orcid.org/0000-0003-1689-3475
Pallesen, Jesper http://orcid.org/0000-0002-3270-1587
Kulp, Dan W. http://orcid.org/0000-0002-0527-3804
Patel, Ami http://orcid.org/0000-0002-2104-9984
Weiner, David B. http://orcid.org/0000-0002-2232-8512
Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (HR0011-21-9-0001)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (T32-AI-055400)
U.S. Department of Health & Human Services | National Institutes of Health (T32-CA-09171)
Public Health Agency of Canada
Article History
Received: 16 May 2022
Accepted: 7 September 2022
First Online: 6 October 2022
Competing interests
: K.S., T.R.F.S., V.M.A., I.M., K.E.B. and J.D.B. are employees of Inovio Pharmaceuticals and as such receives salary and benefits, including ownership of stock and stock options, from the company. J.F, K.R, K.R and M.T.E are employees of and hold or may hold stock in AstraZeneca. S.K.W. is an inventor on US patent (US20190216949) for the AAV6.2FF capsid. D.B.W. has received grant funding, participates in industry collaborations, has received speaking honoraria, and has received fees for consulting, including serving on scientific review committees and board series. Remuneration received by D.B.W. includes direct payments and stock or stock options. D.B.W. also discloses the following paid associations with commercial partners: GeneOne (consultant), Geneos (advisory board), AstraZeneca (advisory board, speaker), Inovio (BOD, SRA, Stock), Sanofi (advisory board) and BBI (advisory board). All other authors declare no completing interests.